Modulation of dopamine release by striatal 5‐HT2C receptors
- 24 January 2005
- Vol. 55 (4), 242-251
- https://doi.org/10.1002/syn.20109
Abstract
Previous work has demonstrated that dopamine (DA) transmission is regulated by serotonin-2C (5-HT2C) receptors but the site(s) in the brain where these receptors are localized is not known. The present work utilized in vivo microdialysis to investigate the modulation of DA release by 5-HT2C receptors localized in the nerve terminal regions of the mesocortical and nigrostriatal DA pathways. Microdialysis probes implanted in the striatum or the prefrontal cortex (PFC) measured dialysate DA concentrations, while the selective 5-HT2B/2C inverse agonist SB 206553 was given locally by reverse dialysis into these terminal regions. Additionally, the effects of the 5-HT2C agonist mCPP on striatal DA were measured. Local administration of SB 206553 (0.1-100 μM) into the striatum increased DA efflux in a concentration-dependent manner. Systemic administration of mCPP (1.0 mg/kg i.p.) decreased striatal DA and attenuated the SB 206553-induced increase. In contrast, infusion of SB 206553 (0.1–500 μM) by reverse dialysis into the PFC had no significant effect on basal DA efflux in this region. Additionally, high concentrations of SB 206553 had no effect on high potassium (K+)-stimulated DA release in the PFC. These data contribute to a body of evidence indicating that 5-HT2C receptors inhibit nigrostriatal dopaminergic transmission. In addition, the results suggest that the nigrostriatal system is regulated by 5-HT2C receptors localized in the dorsal striatum. Elucidating the mechanisms by which serotonin (5-HT) modulates striatal and prefrontocortical DA concentrations may lead to improvements in the treatment of diverse syndromes such as schizophrenia, Parkinson's disease, anxiety, drug abuse, and/or depression. Synapse 55:242–251, 2005. Published 2005 Wiley-Liss, Inc.Keywords
This publication has 44 references indexed in Scilit:
- In Vivo Evidence that 5-HT2C Receptor Antagonist but not Agonist Modulates Cocaine-Induced Dopamine Outflow in the Rat Nucleus Accumbens and StriatumNeuropsychopharmacology, 2003
- Discriminative stimulus properties of (±)-fenfluramine: The role of 5-HT₂ receptor subtypes.Behavioral Neuroscience, 2003
- 5-HT2A and 5-HT2C/2B Receptor Subtypes Modulate Dopamine Release Induced in Vivo by Amphetamine and Morphine in Both the Rat Nucleus Accumbens and StriatumNeuropsychopharmacology, 2002
- Decreased Neuroendocrine Responses to Meta-Chlorophenylpiperazine (m-CPP) but Normal Responses to Ipsapirone in Marathon RunnersNeuropsychopharmacology, 1999
- Global Increases in Seizure Susceptibility in Mice Lacking 5-HT2CReceptors: A Behavioral AnalysisExperimental Neurology, 1998
- Behavioral Effects of 5-HT2CReceptor Antagonism in the Substantia Nigra Zona Reticulata of the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's DiseaseExperimental Neurology, 1998
- Evaluation of Phentermine and Fenfluramine, Alone and in Combination, in Normal, Healthy VolunteersNeuropsychopharmacology, 1996
- Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antiseraNeuropharmacology, 1995
- Acute Effects of Typical and Atypical Antipsychotic Drugs on the Release of Dopamine from Prefrontal Cortex, Nucleus Accumbens, and Striatum of the Rat: An In Vivo Microdialysis StudyJournal of Neurochemistry, 1990
- An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the ratJournal of Comparative Neurology, 1978